Frontlight ResearchEarly access
Trial site
Shengyang
- 1running trial
- 3closed trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer2 trials
- Lung cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 22 trials
- Phase 32 trials
- Status
- Terminated2 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Novartis Pharmaceuticals4 trials
Running trials
Closed trials
Terminated
Terminated
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026